VERU INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
VERU INC. (VERU) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$640.19 thousand for the 3-month period ending 2018-12-31, per its 10-Q filed 2019-02-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2019-02-13
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-12-31 was -$640.19K, a 166.15% decline year-over-year.
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-09-30 was $876.83K.
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-06-30 was $78.37K, a 2719.97% increase year-over-year.
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2018-03-31 was -$591.88K.
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $1.33M.
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was -$981.78K, a 246.62% decline from fiscal 2016.
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was $669.60K, a 39.62% decline from fiscal 2015.
- VERU INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2015 was $1.11M.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$640.19K 10-Q · filed 2019-02-13 | $236.65K derived: sum of 2 quarters · filed 2019-02-13 | $315.01K derived: sum of 3 quarters · filed 2019-02-13 | -$276.87K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2018-09-30 | $876.83K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $955.20K derived: sum of 2 quarters · filed 2018-12-13 | $363.32K derived: sum of 3 quarters · filed 2018-12-13 | $1.33M 10-K · filed 2018-12-13 | |
| 2018-06-30 | $78.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$513.51K derived: sum of 2 quarters · filed 2018-08-14 | $454.32K 10-Q · filed 2018-08-14 | $387.31K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2018-03-31 | -$591.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | $375.96K 10-Q · filed 2018-05-11 | $308.94K derived: sum of 3 quarters · filed 2019-02-13 | $311.72K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-12-31 | $967.84K 10-Q · filed 2019-02-13 | $900.82K derived: sum of 2 quarters · filed 2019-02-13 | $903.60K derived: sum of 3 quarters · filed 2019-02-13 | -$251.62K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-09-30 | -$67.02K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | -$64.24K derived: sum of 2 quarters · filed 2018-12-13 | -$1.22M derived: sum of 3 quarters · filed 2018-12-13 | -$981.78K 10-K · filed 2018-12-13 | |
| 2017-06-30 | $2.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$1.15M derived: sum of 2 quarters · filed 2018-08-14 | -$914.76K 10-Q · filed 2018-08-14 | -$931.21K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | -$917.54K 10-Q · filed 2018-05-11 | -$933.99K derived: sum of 3 quarters · filed 2018-05-11 | -$922.67K derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $237.68K 10-Q · filed 2018-02-14 | $221.23K derived: sum of 2 quarters · filed 2018-02-14 | $232.55K derived: sum of 3 quarters · filed 2018-02-14 | $756.71K derived: sum of 4 quarters · filed 2018-02-14 | |
| 2016-09-30 | -$16.45K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$5.13K derived: sum of 2 quarters · filed 2018-01-02 | $519.03K derived: sum of 3 quarters · filed 2018-01-02 | $669.60K 10-K · filed 2018-01-02 | |
| 2016-06-30 | $11.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $535.48K derived: sum of 2 quarters · filed 2017-08-09 | $686.05K 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $524.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $674.73K 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | $150.57K 10-Q · filed 2017-02-09 | ||||
| 2015-09-30 | $1.11M 10-K · filed 2018-01-02 | ||||
| 2014-09-30 | -$270.31K 10-K · filed 2016-12-12 | ||||
| 2013-09-30 | -$1.65M 10-K · filed 2015-12-02 | -$1.63M 10-K · filed 2013-12-03 | |||
| 2012-09-30 | $2.82M 10-K · filed 2014-12-02 | $2.84M 10-K · filed 2012-12-04 | |||
| 2011-09-30 | -$30.96K 10-K · filed 2013-12-03 | ||||
| 2010-09-30 | -$2.90M 10-K · filed 2012-12-04 | ||||
| 2009-09-30 | $1.66M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |